Funder
National Evidence-based Healthcare Collaborating Agency
Reference5 articles.
1. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial;Shah;Lancet,2022
2. Study of the effect of Occlutech Atrial Flow Regulator on symptoms, hemodynamics, and echocardiographic parameters in advanced pulmonary arterial hypertension;Sivakumar;Pulm Circ,2021
3. Implantation of atrial flow regulator devices in patients with congenital heart disease and children with severe pulmonary hypertension or cardiomyopathy-an international multicenter case series;Butera;Front Cardiovasc Med,2024
4. Feasibility, safety, and efficacy of atrial flow regulator in children under 10 kg;Bautista-Rodriguez;Catheter Cardiovasc Interv,2023
5. Stenting of the inter-atrial septum in infants and small children: indications, techniques and outcomes;Mainzer;Catheter Cardiovasc Interv,2018